Marvipol Growth () Third Quarter 2022 Outcomes
Key Monetary Outcomes
- Income: zł85.3m (down 55% from 3Q 2021).
- Internet revenue: zł18.9m (down 46% from 3Q 2021).
- Revenue margin: 22% (up from 19% in 3Q 2021). The rise in margin was pushed by decrease bills.
- EPS: zł0.45 (down from zł0.84 in 3Q 2021).
All figures proven within the chart above are for the trailing 12 month (TTM) interval
Marvipol Growth shares are up 1.1% from every week in the past.
What about dangers? Each firm has them, and we have noticedit is best to learn about.
Valuation is complicated, however we’re serving to make it easy.
Discover out whether or not Marvipol Growth is probably over or undervalued by trying out our complete evaluation, which incorporates truthful worth estimates, dangers and warnings, dividends, insider transactions and monetary well being.
Have suggestions on this text? Involved concerning the content material?with us immediately. Alternatively, electronic mail editorial-team (at) simplywallst.com.
This text by Merely Wall St is basic in nature. We offer commentary primarily based on historic information and analyst forecasts solely utilizing an unbiased methodology and our articles should not supposed to be monetary recommendation. It doesn’t represent a suggestion to purchase or promote any inventory, and doesn’t take account of your targets, or your monetary state of affairs. We goal to carry you long-term targeted evaluation pushed by basic information. Observe that our evaluation might not issue within the newest price-sensitive firm bulletins or qualitative materials. Merely Wall St has no place in any shares talked about.